Patenting The Recombinant Products Of Biotechnology And Other Molecules
This work examines the requirements for patentability in the context of biotechnology, with a special focus on the non-obviousness requirement. It analyses non-obviousness as applied to biotechnology molecular products via a review of the relevant case law. The work begins with a typology of recombinant inventions, useful in determining ultimate non-obviousness and patentability.\ It distinguishes three categories of recombinant products:\ \ 'Translation' inventions, obtained by entering a...
Search in google:
This work examines the requirements for patentability in the context of biotechnology, with a special focus on the non-obviousness requirement. It analyses non-obviousness as applied to biotechnology molecular products via a review of the relevant
IntroductionPatent Law PrimerRecombinant Products and the Standard for Obviousness: A Typology In re Deuel: The Federal Circuit and `Translation' DNAsGeneralization of a Concept: Other Biotechnology Products are `Translation' InventionsConsequences and Remedies
